These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8857304)

  • 1. The chemotherapeutic effects of H+/K+ inhibitors on Helicobacter pylori infection.
    Logan RP
    Pharmacol Ther; 1996; 69(1):79-83. PubMed ID: 8857304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori.
    Nakao M; Malfertheiner P
    Helicobacter; 1998 Mar; 3(1):21-7. PubMed ID: 9546114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies.
    Dickey W; Kenny BD; McConnell JB
    Aliment Pharmacol Ther; 1996 Jun; 10(3):289-93. PubMed ID: 8791953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country.
    Ahuja V; Dhar A; Bal C; Sharma MP
    Aliment Pharmacol Ther; 1998 Jun; 12(6):551-5. PubMed ID: 9678815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.
    Suzuki M; Suzuki H; Kitahora T; Miyazawa M; Nagahashi S; Suzuki K; Ishii H
    Aliment Pharmacol Ther; 2002 Jan; 16(1):159-65. PubMed ID: 11856091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer.
    Sugiyama T; Hisano K; Ochiai T; Fujita N; Kobayashi T; Yabana T; Kurokawa I; Yachi A
    J Clin Gastroenterol; 1995; 20 Suppl 2():S104-6. PubMed ID: 7594322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
    Magaret N; Burm M; Faigel D; Kelly C; Peterson W; Fennerty MB
    Dig Dis; 2001; 19(2):174-8. PubMed ID: 11549829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor.
    Tsuchiya M; Imamura L; Park JB; Kobashi K
    Biol Pharm Bull; 1995 Aug; 18(8):1053-6. PubMed ID: 8535394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease.
    Nagata K; Takagi E; Tsuda M; Nakazawa T; Satoh H; Nakao M; Okamura H; Tamura T
    Antimicrob Agents Chemother; 1995 Feb; 39(2):567-70. PubMed ID: 7726537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.
    Miwa H; Ohkura R; Murai T; Sato K; Nagahara A; Hirai S; Watanabe S; Sato N
    Aliment Pharmacol Ther; 1999 Jun; 13(6):741-6. PubMed ID: 10383502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of lansoprazole in eradication of Helicobacter pylori.
    Takimoto T; Ido K; Taniguchi Y; Satoh K; Saifuku K; Kihira K; Yoshida Y; Kimura K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S121-4. PubMed ID: 7594327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
    Wong BC; Xiao SD; Hu FL; Qian SC; Huang NX; Li YY; Hu PJ; Daldiyono ; Manan C; Lesmana L; Carpio RE; Perez JY; Fock KM; Kachintorn U; Phornphutkul K; Kullavanijaya P; Ho J; Lam SK
    Aliment Pharmacol Ther; 2000 Feb; 14(2):217-24. PubMed ID: 10651663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection.
    Spinzi GC; Bierti L; Bortoli A; Colombo E; Fertitta AM; Lanzi GL; Venturelli R; Minoli G
    Aliment Pharmacol Ther; 1998 May; 12(5):433-8. PubMed ID: 9663722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
    Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H
    World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
    Louw JA; Van Rensburg CJ; Moola S; Kotze D; Marks IN
    Aliment Pharmacol Ther; 1998 Sep; 12(9):881-5. PubMed ID: 9768531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lansoprazole on Helicobacter pylori.
    Lamouliatte H
    Clin Ther; 1993; 15 Suppl B():32-6. PubMed ID: 8205593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori.
    Caselli M; Trevisani L; Tursi A; Sartori S; Ruina M; Luzzi I; Gaudenzi P; Alvisi V; Gasbarrini G
    Eur J Gastroenterol Hepatol; 1997 Jan; 9(1):45-8. PubMed ID: 9031898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.
    Nakao M; Tada M; Tsuchimori K; Uekata M
    Eur J Clin Microbiol Infect Dis; 1995 May; 14(5):391-9. PubMed ID: 7556227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors.
    Dattilo M; Figura N
    J Clin Gastroenterol; 1998; 27 Suppl 1():S163-9. PubMed ID: 9872516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.